FDA and pharma seek better ways to assess drug safety, efficacy in clinical trials.
Mike
M
Mitka
D015982:Bias; D003625:Data Collection / Q000592:standards; D017277:Drug Approval; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D017598:Efficiency, Organizational; D057194:Intention to Treat Analysis; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014481:United States; D014486:United States Food and Drug Administration